Synthesis, characterization, and biodistribution of multiple 89Zr-labeled pore-expanded mesoporous silica nanoparticles for PET. (Q53073005)

11 May 2018

title

Synthesis, characterization, and biodistribution of multiple 89Zr-labeled pore-expanded mesoporous silica nanoparticles for PET. (English)

1 reference

11 May 2018

0 references

Larissa Miller

1

1 reference

11 May 2018

Gordon Winter

2

1 reference

11 May 2018

Benjamin Baur

3

1 reference

11 May 2018

Barbara Witulla

4

1 reference

11 May 2018

Christoph Solbach

5

1 reference

11 May 2018

Sven Reske

6

1 reference

11 May 2018

Mika Lindén

7

1 reference

11 May 2018

language of work or name

English

0 references

publication date

1 May 2014

1 reference

11 May 2018

published in

Nanoscale

1 reference

11 May 2018

volume

6

1 reference

11 May 2018

issue

9

1 reference

11 May 2018

page(s)

4928-4935

1 reference

11 May 2018

Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

Functionalization of mesoporous silica nanoparticles for targeting, biocompatibility, combined cancer therapies and theragnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

Mesoporous silica nanoparticles in medicine--recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

Silica-based nanoprobes for biomedical imaging and theranostic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

Standardized methods for the production of high specific-activity zirconium-89.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

Size and shape effects in the biodistribution of intravascularly injected particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR06800E

21 January 2018

Identifiers

DOI

10.1039/C3NR06800E

1 reference

11 May 2018

PubMed ID

24675844

1 reference

11 May 2018